Morphic Therapeutic Announces Initiation of EMERALD-1 Phase 2a Clinical Trial of MORF-057 in Patients with Ulcerative Colitis
MORF-057, an oral α4β7 integrin inhibitor candidate, holds potential for treating inflammatory bowel diseases Phase…
News
Icosavax Announces Topline Interim Phase 1/2 Results for IVX-411 Against SARS-CoV-2
– Immunologic response observed in both SARS-CoV-2 naive and previously vaccinated subjects, but lower than…
Timber Pharmaceuticals Announces Late-Breaking Presentation at the American Academy of Dermatology 2022 Annual Meeting
Sub-analysis of the Phase 2b CONTROL study in congenital ichthyosis demonstrates treatment success with TMB-001…
ORYZON to Give Updates on Corporate Progress in March and April
Virtual Bio-Europe Spring 2022 Kempen Life Sciences Conference Asebio Investor Day MADRID, Spain and CAMBRIDGE,…
Heat Biologics Unveils Enhanced Allogeneic Cell Manufacturing Process
New 3-D process designed to increase yield and improve operating efficiency for rapid and scalable…
Arcutis Presents New Data on Once-Daily Roflumilast Cream for Plaque Psoriasis from DERMIS Phase 3 Trials at American Academy of Dermatology Annual Meeting
Pooled analysis of DERMIS-1 and DERMIS-2 demonstrated significantly more roflumilast-treated patients achieved Investigator Global Assessment…
Arcutis’ Roflumilast Foam Demonstrates Clinically Meaningful Results and Patient Quality of Life Improvements in Phase 2 Seborrheic Dermatitis Study
Previously reported data demonstrated that roflumilast foam provided statistically significant improvement in disease severity and…
Acasti Pharma Appoints Healthcare Industry Leader Michael L. Derby to its Board of Directors
LAVAL, Quebec, March 25, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”)…
Aleafia Health Continues to Gain Share in Adult Use Cannabis Market and Drive International Sales Growth
Reached new record market share overall adult use market share of 2.06% in February 2022,…
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Global Phase 2b trial for eblasakimab in moderate-to-severe atopic dermatitis (AD) underway with topline data…
Vaccitech Reports Full-Year 2021 Financial Results and Recent Corporate Developments
OXFORD, United Kingdom, March 25, 2022 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC) today announced…
ADMA Biologics Announces FDA Approval of Extended Shelf Life for ASCENIV™ & BIVIGAM® from 24 to 36 Months
Approval of 36-month shelf life encompasses all ASCENIV & BIVIGAM vial sizes, production scales, as…
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
BALA CYNWYD, Pa., March 25, 2022 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
Tiziana Announces Initiation of Phase 1b Clinical Trial in Crohn’s Disease Patients to Evaluate Oral Capsules of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody
This clinical trial, the first-ever oral immunotherapy for patients with mild-to-moderately active Crohn’s Disease, is…
Fennec Pharmaceuticals to Participate in the 2022 Maxim Virtual Growth Conference
RESEARCH TRIANGLE PARK, N.C., March 25, 2022 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ: FENC;…
Announcing Sprouts AI’s Auditor, Debt Financing Opportunity, and the Promotion of Carlos Zapata to COO
Calgary, Alberta–(Newsfile Corp. – March 25, 2022) – Sprout AI Inc. (CSE: BYFM) (OTCQB: BYFMF)…
Aavegotchi Announces Launch Date for GameFi Metaverse, The Gotchiverse
Gotchiverse launching March 31, 2022 Singapore, Singapore–(Newsfile Corp. – March 25, 2022) – Pixelcraft Studios’…
JTOWER and DOCOMO Agreed to the Master Transaction Agreement for Infra-Sharing of Existing Telecommunications Towers
TOKYO, Mar 25, 2022 – (JCN Newswire) – JTOWER Inc. (“JTOWER”) and NTT DOCOMO, INC….
WarSindia Announces Whitelist Competition Date
Sydney, Australia, Mar 25, 2022 – (ACN Newswire) – WarSindia, the first Esports-to-earn NFT game…
GONGGANTECH of Korea, Introduces Earthquake-Resistant Ceiling lightweight Steel Frame that Will Change the Paradigm of Construction
Seoul, Korea, Mar 25, 2022 – (ACN Newswire) – GONGGANTECH is proud to announce the…